Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Vitamin K antagonists vs heparin Bleeding ‐ clinically indicated non‐major Treatment duration 28 ‐ 42 days · people requiring prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee… (2016) · Cochrane | no estimate extracted | NR | No studies |
Heparin vs placebo Clinically relevant non‐major bleeding Treatment duration 28 ‐ 42 days · people requiring prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee… (2016) · Cochrane | no estimate extracted | NR | No studies |
Active cancer therapy combined with TCM vs active cancer therapy All‐cause mortality ‐ not reported · patients with oesophageal cancer Chinese herbal medicine for oesophageal cancer (2016) · Cochrane | no estimate extracted | NR | No studies |
Active cancer therapy combined with TCM vs active cancer therapy Median survival times ‐ not reported · patients with oesophageal cancer Chinese herbal medicine for oesophageal cancer (2016) · Cochrane | no estimate extracted | NR | No studies |
Active cancer therapy combined with TCM vs active cancer therapy Time to progression ‐ not reported · patients with oesophageal cancer Chinese herbal medicine for oesophageal cancer (2016) · Cochrane | no estimate extracted | NR | No studies |
Patching vs no patching Quality of life · participants with corneal abrasion Patching for corneal abrasion (2016) · Cochrane | no estimate extracted | NR | No studies |
Low‐dose aspirin vs placebo or no treatment Other adverse events · Women with subfertility Aspirin for in vitro fertilisation (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Length of time with fever ‐ not reported · treating infections in people with neutropenia or neutrophil dysfunction Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Number of days on therapeutic antibiotics ‐ not reported · treating infections in people with neutropenia or neutrophil dysfunction Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Number of adverse events requiring discontinuation of treatment ‐ not reported · treating infections in people with neutropenia or neutrophil dysfunction Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Quality of life ‐ not reported · treating infections in people with neutropenia or neutrophil dysfunction Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Severe adverse effects (G3/4) outcomes · Women with newly diagnosed epithelial ovarian cancer Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer (2016) · Cochrane | no estimate extracted | NR | No studies |
Corticosteroids vs placebo Change in nerve pain and in nerve tenderness at 1 year ‐ not reported · people with nerve damage (6 to 24 months' duration) in leprosy Corticosteroids for treating nerve damage in leprosy (2016) · Cochrane | no estimate extracted | NR | No studies |
Corticosteroids vs placebo Limitations in activities of daily living at 1 year ‐ not reported · people with nerve damage (6 to 24 months' duration) in leprosy Corticosteroids for treating nerve damage in leprosy (2016) · Cochrane | no estimate extracted | NR | No studies |
Corticosteroids vs placebo Limitations in participation at 1 year ‐ not reported · people with nerve damage (6 to 24 months' duration) in leprosy Corticosteroids for treating nerve damage in leprosy (2016) · Cochrane | no estimate extracted | NR | No studies |
Corticosteroids vs placebo Improvement in motor nerve function at 1 year ‐ not reported · people with nerve damage (< 6 months' duration) in leprosy Corticosteroids for treating nerve damage in leprosy (2016) · Cochrane | no estimate extracted | NR | No studies |
Corticosteroids vs placebo Change in nerve pain and in nerve tenderness at 1 year ‐ not reported · people with nerve damage (< 6 months' duration) in leprosy Corticosteroids for treating nerve damage in leprosy (2016) · Cochrane | no estimate extracted | NR | No studies |
Corticosteroids vs placebo Limitations in activities of daily living at 1 year ‐ not reported · people with nerve damage (< 6 months' duration) in leprosy Corticosteroids for treating nerve damage in leprosy (2016) · Cochrane | no estimate extracted | NR | No studies |
Corticosteroids vs placebo Limitations in participation at 1 year ‐ not reported · people with nerve damage (< 6 months' duration) in leprosy Corticosteroids for treating nerve damage in leprosy (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Radiographic evaluation Aquatic exercise for the treatment of knee and hip osteoarthritis (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Short term serious adverse effects from trials Aquatic exercise for the treatment of knee and hip osteoarthritis (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Long term adverse effects or toxicity from observational studies Aquatic exercise for the treatment of knee and hip osteoarthritis (2016) · Cochrane | no estimate extracted | NR | No studies |
CSII vs MDI: infant outcomes Adiposity (infant) · infants of pregnant women with diabetes Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with… (2016) · Cochrane | no estimate extracted | NR | No studies |
CSII vs MDI: infant outcomes Neurosensory disability · infants of pregnant women with diabetes Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with… (2016) · Cochrane | no estimate extracted | NR | No studies |
CSII vs MDI: infant outcomes Large‐for‐gestational age · infants of pregnant women with diabetes Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with… (2016) · Cochrane | no estimate extracted | NR | No studies |
CSII vs MDI: infant outcomes Neonatal hypoglycaemia · infants of pregnant women with diabetes Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with… (2016) · Cochrane | no estimate extracted | NR | No studies |
Prophylactic cholinesterase inhibitor vs placebo Return to independent living ‐ not measured Interventions for preventing delirium in hospitalised non‐ICU patients (2016) · Cochrane | no estimate extracted | NR | No studies |
Prophylactic cholinesterase inhibitor vs placebo Inpatient mortality ‐ not measured Interventions for preventing delirium in hospitalised non‐ICU patients (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Return to independent living ‐ not measured Interventions for preventing delirium in hospitalised non‐ICU patients (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Inpatient mortality ‐ not measured Interventions for preventing delirium in hospitalised non‐ICU patients (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Return to independent living ‐ not measured Interventions for preventing delirium in hospitalised non‐ICU patients (2016) · Cochrane | no estimate extracted | NR | No studies |
Bispectral index (BIS)‐guided anaesthesia vs BIS‐blinded anaesthesia/clinical judgement Duration of delirium ‐ not measured Interventions for preventing delirium in hospitalised non‐ICU patients (2016) · Cochrane | no estimate extracted | NR | No studies |
Bispectral index (BIS)‐guided anaesthesia vs BIS‐blinded anaesthesia/clinical judgement Severity of delirium ‐ not measured Interventions for preventing delirium in hospitalised non‐ICU patients (2016) · Cochrane | no estimate extracted | NR | No studies |
Bispectral index (BIS)‐guided anaesthesia vs BIS‐blinded anaesthesia/clinical judgement Return to independent living ‐ not measured Interventions for preventing delirium in hospitalised non‐ICU patients (2016) · Cochrane | no estimate extracted | NR | No studies |
Bispectral index (BIS)‐guided anaesthesia vs BIS‐blinded anaesthesia/clinical judgement In‐hospital mortality ‐ not measured Interventions for preventing delirium in hospitalised non‐ICU patients (2016) · Cochrane | no estimate extracted | NR | No studies |
Prophylactic cholinesterase inhibitor vs placebo Duration of delirium ‐ not measured Interventions for preventing delirium in hospitalised non‐ICU patients (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Proportion of maternal participants with desaturation1 · low‐risk term pregnant women undergoing elective caesarean section under regional anaesthesia Supplemental oxygen for caesarean section during regional anaesthesia (2016) · Cochrane | no estimate extracted | NR | No studies |
Chromoscopy vs conventional colonoscopy Adverse events · people undergoing colonoscopy for the detection of polyps Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum (2016) · Cochrane | no estimate extracted | NR | No studies |
Non‐exclusive breastfeeding (water or glucose water) vs exclusive breastfeeding Confidence in breastfeeding (maternal or of those influencing the mother) · healthy breastfeeding full‐term infants Early additional food and fluids for healthy breastfed full‐term infants (2016) · Cochrane | no estimate extracted | NR | No studies |
Non‐exclusive breastfeeding (foods) vs exclusive breastfeeding Duration of breastfeeding (at different time points) · healthy breastfeeding full‐term infants Early additional food and fluids for healthy breastfed full‐term infants (2016) · Cochrane | no estimate extracted | NR | No studies |
Non‐exclusive breastfeeding (foods) vs exclusive breastfeeding Confidence in breastfeeding (maternal or of those influencing the mother) · healthy breastfeeding full‐term infants Early additional food and fluids for healthy breastfed full‐term infants (2016) · Cochrane | no estimate extracted | NR | No studies |
Non‐exclusive breastfeeding (artificial milk) vs exclusive breastfeeding Weight change · healthy breastfeeding full‐term infants Early additional food and fluids for healthy breastfed full‐term infants (2016) · Cochrane | no estimate extracted | NR | No studies |
Oral iron vs placebo or no treatment Subgroup · children in malaria‐endemic areas Oral iron supplements for children in malaria‐endemic areas (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Subgroup · children in malaria‐endemic areas Oral iron supplements for children in malaria‐endemic areas (2016) · Cochrane | no estimate extracted | NR | No studies |
Comparison between rooming‐in vs separate care Duration of any breastfeeding · 176 healthy mother‐infant dyads after normal spontaneous vaginal delivery (rooming‐in: 132, separate care: 44) Rooming‐in for new mother and infant versus separate care for increasing the duration of breastfeeding (2016) · Cochrane | no estimate extracted | NR | No studies |
Comparison between rooming‐in vs separate care Proportion of women exclusive breastfeeding at 6 months · 176 healthy mother‐infant dyads after normal spontaneous vaginal delivery (rooming‐in: 132, separate care: 44) Rooming‐in for new mother and infant versus separate care for increasing the duration of breastfeeding (2016) · Cochrane | no estimate extracted | NR | No studies |
Comparison between rooming‐in vs separate care Maternal level of confidence in breastfeeding · 176 healthy mother‐infant dyads after normal spontaneous vaginal delivery (rooming‐in: 132, separate care: 44) Rooming‐in for new mother and infant versus separate care for increasing the duration of breastfeeding (2016) · Cochrane | no estimate extracted | NR | No studies |
Comparison between rooming‐in vs separate care Neonatal infection · 176 healthy mother‐infant dyads after normal spontaneous vaginal delivery (rooming‐in: 132, separate care: 44) Rooming‐in for new mother and infant versus separate care for increasing the duration of breastfeeding (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Changes in globotriaosylceramide (Gb3) concentration in plasma and tissue · Anderson‐Fabry disease Enzyme replacement therapy for Anderson‐Fabry disease (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Pain Acroparaesthesia and Fabry crises · Anderson‐Fabry disease Enzyme replacement therapy for Anderson‐Fabry disease (2016) · Cochrane | no estimate extracted | NR | No studies |